Lithium & Mood Stabilizers at Psych Congress 2026

4 sessions on lithium & mood stabilizers · September 15–19, 2026, New Orleans, LA. Compare lithium & mood stabilizers at other meetings →

Tuesday, September 15

Lecture · Difficult Medicines
Difficult Medicines: The Art and Science of Lithium Therapy
Jonathan M. Meyer
Practical deep dive on lithium's mechanisms and dosing precision, including monitoring, toxicity mitigation, adherence, and use in special populations.
Drug Interactions & Safety

Lecture · Bipolar Disorders
Complex Psychopharmacology in Bipolar Disorder: Combination Therapy, Dosing Pearls & Side-Effect Navigation
Joseph Goldberg
Advanced guidance on sequencing lithium, anticonvulsants, and atypical antipsychotics in bipolar disorder, with case vignettes on inadequate response, intolerability, and polypharmacy.
Antipsychotic Prescribing · Bipolar Disorder · Deprescribing & Polypharmacy
Symposium · AFSP Partner Session
Suicide Prevention in Psychiatric Practice: A Logical, Evidence-Based Framework
Jill Harkavy-Friedman · Cory Weissman
Reviews treatments with demonstrated anti-suicidal benefit — lithium, clozapine, ECT, and CBT-based approaches — within a structured framework for individualized prevention planning. Developed with the American Foundation for Suicide Prevention.
Clozapine · Neuromodulation (ECT, TMS) · Suicide & Self-Harm

Symposium · MDD
Modern Psychopharmacology for MDD: Switching, Sequencing, and Augmentation Strategies for Partial Responders
Mark Zimmerman · Shelley Matthews
Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.
Depression · Novel Antidepressants · Treatment-Resistant Depression